Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 101635, 8 pages
http://dx.doi.org/10.1155/2014/101635
Research Article

Antimicrobial Resistance Pattern and Their Beta-Lactamase Encoding Genes among Pseudomonas aeruginosa Strains Isolated from Cancer Patients

1Department of Microbiology and Immunology, Faculty of Pharmacy, Ahram Canadian University, Cairo, Egypt
2Department of Pharmaceutics and Microbiology, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia
3Department of Microbiology and Immunology, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt
4Department of Clinical Pathology, National Cancer Institute, Cairo University, Cairo, Egypt
5Department of Microbiology and Immunology, Faculty of Pharmacy, Cairo University, Cairo, Egypt
6Department of Microbiology and Immunology, Faculty of Pharmacy, Modern Science and Arts University, 6th October City, Giza, Egypt

Received 15 September 2013; Revised 7 January 2014; Accepted 14 January 2014; Published 23 February 2014

Academic Editor: Branka Bedenic

Copyright © 2014 Mai M. Zafer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. W. Wirth, S. U. Picoli, V. V. Cantarelli et al., “Metallo-β-lactamase-producing Pseudomonas aeruginosa in two hospitals from Southern Brazil,” Brazilian Journal of Infectious Diseases, vol. 13, no. 3, pp. 170–172, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. M.-L. Lambert, C. Suetens, A. Savey et al., “Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study,” The Lancet Infectious Diseases, vol. 11, no. 1, pp. 30–38, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. E. F. Keen III, B. J. Robinson, D. R. Hospenthal et al., “Prevalence of multidrug-resistant organisms recovered at a military burn center,” Burns, vol. 36, no. 6, pp. 819–825, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. D. K. Mendiratta, V. Deotale, and P. Narang, “Mettallo-β-lactamase producing Pseudomonas aeruginosa in a hospital from a rural area,” Indian Journal of Medical Research, vol. 121, no. 5, pp. 701–703, 2005. View at Google Scholar · View at Scopus
  5. W. H. Zhao and Z. Q. Hu, “β-lactamases identified in clinical isolates of Pseudomonas aeruginosa,” Critical Reviews in Microbiology, vol. 36, no. 3, pp. 245–258, 2010. View at Publisher · View at Google Scholar
  6. J. Wang, J.-Y. Zhou, T.-T. Qu et al., “Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals,” International Journal of Antimicrobial Agents, vol. 35, no. 5, pp. 486–491, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Mirsalehian, M. Feizabadi, F. A. Nakhjavani, F. Jabalameli, H. Goli, and N. Kalantari, “Detection of VEB-1, OXA-10 and PER-1 genotypes in extended-spectrum β-lactamase-producing Pseudomonas aeruginosa strains isolated from burn patients,” Burns, vol. 36, no. 1, pp. 70–74, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. A. W. Bauer, W. M. Kirby, J. C. Sherris, and M. Turck, “Antibiotic susceptibility testing by a standardized single disk method,” American Journal of Clinical Pathology, vol. 45, no. 4, pp. 493–496, 1966. View at Google Scholar · View at Scopus
  9. Clinical and Laboratory Standards Institute, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically: Approved Standard M7-A7, CLSI, Wayne, Pa, USA, 7th edition, 2010.
  10. Y. Glupczynski, P. Bogaerts, A. Deplano et al., “Detection and characterization of class A extended-spectrum-β-lactamase-producing Pseudomonas aeruginosa isolates in Belgian hospitals,” Journal of Antimicrobial Chemotherapy, vol. 65, no. 5, pp. 866–871, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Bashir, M. A. Thokar, B. A. Fomda et al., “Detection of metallo-β-lactamase (MBL) producing Pseudomonas aeruginosa at a tertiary care hospital in Kashmir,” African Journal of Microbiology Research, vol. 5, no. 2, pp. 164–172, 2011. View at Google Scholar · View at Scopus
  12. S. Lee, Y.-J. Park, M. Kim et al., “Prevalence of Ambler class A and D β-lactamases among clinical isolates of Pseudomonas aeruginosa in Korea,” Journal of Antimicrobial Chemotherapy, vol. 56, no. 1, pp. 122–127, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Alipour, N. Sadeghifard, N. Amirmozafari et al., “Incidence of extended spectrum β-lactamase producing Pseudomonas aeruginosa and frequency of OXA-2 and OXA-10 genes,” Australian Journal of Basic and Applied Sciences, vol. 4, no. 8, pp. 3202–3207, 2010. View at Google Scholar · View at Scopus
  14. J.-J. Yan, P.-R. Hsueh, W.-C. Ko et al., “Metallo-β-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme,” Antimicrobial Agents and Chemotherapy, vol. 45, no. 8, pp. 2224–2228, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. M. J. Ellington, J. Kistler, D. M. Livermore, and N. Woodford, “Multiplex PCR for rapid detection of genes encoding acquired metallo-β-lactamases,” Journal of Antimicrobial Chemotherapy, vol. 59, no. 2, pp. 321–322, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Kaase, P. Nordmann, T. A. Wichelhaus, S. G. Gatermann, R. A. Bonnin, and L. Poirel, “NDM-2 carbapenemase in Acinetobacter baumannii from Egypt,” Journal of Antimicrobial Chemotherapy, vol. 66, no. 6, pp. 1260–1262, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. B. A. Mahmoud, A. W. Zahran, R. G. Hindawi, Z. A. Labib, and R. Galal, “Prevalence of multidrug-resistant Pseudomonas aeruginosa in patients with nosocomial infections at a university hospital in Egypt, with special reference to typing methods,” Journal of Virology & Microbiology, vol. 2013, Article ID 290047, 13 pages, 2013. View at Publisher · View at Google Scholar
  18. R. C. Picão, L. Poirel, A. C. Gales, and P. Nordmann, “Diversity of β-lactamases produced by ceftazidime-resistant Pseudomonas aeruginosa isolates causing bloodstream infections in Brazil,” Antimicrobial Agents and Chemotherapy, vol. 53, no. 9, pp. 3908–3913, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. H. M. Ashour and A. El-Sharif, “Species distribution and antimicrobial susceptibility of gram-negative aerobic bacteria in hospitalized cancer patients,” Journal of Translational Medicine, vol. 7, article 14, pp. 1–13, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. A. A. Mohamed, A. M. Shibl, S. A. Zaki, and A. F. Tawfik, “Antimicrobial resistance pattern and prevalence of metallo-β-lactamases in Pseudomonas aeruginosa from Saudi Arabia,” African Journal of Microbiology Research, vol. 5, no. 30, pp. 5528–5533, 2011. View at Publisher · View at Google Scholar
  21. M. Souli, I. Galani, and H. Giamarellou, “Emergence of extensively drug-resistant and pandrug-resistant gram-negative bacilli in Europe,” Euro Surveillance, vol. 13, no. 47, pp. 1–11, 2008. View at Google Scholar · View at Scopus
  22. M. A. Bahar, S. Jamali, and A. Samadikuchaksaraei, “Imipenem-resistant Pseudomonas aeruginosa strains carry metallo-β-lactamase gene blaVIM in a level I Iranian burn hospital,” Burns, vol. 36, no. 6, pp. 826–830, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. S. A. Mansour, O. Eldaly, A. J. Fatani, M. L. Mohamed, and E. M. Ibrahim, “Epidemiological characterization of P. aeruginosa isolates of intensive care units in Egypt and Saudi Arabia,” Eastern Mediterranean Health Journal, vol. 19, no. 1, pp. 71–80, 2013. View at Google Scholar
  24. A. S. De, S. H. Kumar, and S. M. Baveja, “Prevalence of metallo-β-lactamase producing Pseudomonas aeruginosa and Acinetobacter species in intensive care areas in a tertiary care hospital,” Indian Journal of Critical Care Medicine, vol. 14, no. 4, pp. 217–219, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. T. R. Walsh, H. Li, M. A. Toleman, P. M. Bennett, and R. N. Jones, “Complete sequence of p07-406, a 24,179-base-pair plasmid harboring the blaVIM-7 metallo-β-lactamase gene in a Pseudomonas aeruginosa isolate from the United States,” Antimicrobial Agents and Chemotherapy, vol. 52, no. 9, pp. 3099–3105, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Elias, C. Schoen, G. Heinze et al., “Nosocomial outbreak of VIM-2 metallo-β-lactamase-producing Pseudomonas aeruginosa associated with retrograde urography,” Clinical Microbiology and Infection, vol. 16, no. 9, pp. 1494–1500, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Hocquet, P. Plésiat, B. Dehecq, P. Mariotte, D. Talon, and X. Bertrand, “Nationwide investigation of extended-spectrum β-lactamases, metallo-β-lactamases, and extended-spectrum oxacillinases produced by ceftazidime-resistant Pseudomonas aeruginosa strains in France,” Antimicrobial Agents and Chemotherapy, vol. 54, no. 8, pp. 3512–3515, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Poirel, T. Naas, and P. Nordmann, “Diversity, epidemiology, and genetics of class D β-lactamases,” Antimicrobial Agents and Chemotherapy, vol. 54, no. 1, pp. 24–38, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. M. A. Gharib, N. H. Ouda, M. Saeed, L. Hamed, and S. M. Abdel Rahman, “Prevalence of extended spectrum beta lactamase producers in an Egyptian Critical Care Center,” Egyptian Journal of Medical Microbiology, vol. 18, no. 4, pp. 139–145, 2009. View at Google Scholar
  30. F. Jabalameli, A. Mirsalehian, N. Sotoudeh et al., “Multiple-locus variable number of tandem repeats (VNTR) fingerprinting (MLVF) and antibacterial resistance profiles of extended spectrum beta lactamase (ESBL) producing Pseudomonas aeruginosa among burnt patients in Tehran,” Burns, vol. 37, no. 7, pp. 1202–1207, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Shahcheraghi, V.-S. Nikbin, and M. M. Feizabadi, “Prevalence of ESBLs genes among multidrug-resistant isolates of Pseudomonas aeruginosa isolated from patients in Tehran,” Microbial Drug Resistance, vol. 15, no. 1, pp. 37–39, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. D. J. Wolter, N. Khalaf, I. E. Robledo et al., “Surveillance of carbapenem-resistant Pseudomonas aeruginosa isolates from Puerto Rican Medical Center Hospitals: dissemination of KPC and IMP-18 β-lactamases,” Antimicrobial Agents and Chemotherapy, vol. 53, no. 4, pp. 1660–1664, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. A. F. Tawfik, A. M. Shibl, M. A. Aljohi, M. A. Altammami, and M. H. Al-Agamy, “Distribution of Ambler class A, B and D β-lactamases among Pseudomonas aeruginosa isolates,” Burns, vol. 38, no. 6, pp. 855–860, 2012. View at Publisher · View at Google Scholar · View at Scopus